Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

93 results
Display

A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma

Kim SJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comprehensive Identification of Tumor-associated Antigens via Isolation of Human Monoclonal Antibodies that may be Therapeutic

Kurosawa Y

Although the success of trastuzumab and rituximab for treatment of breast cancer and non-Hodgkins lymphoma, respectively, suggests that monoclonal antibodies (mAbs) will become important therapeutic agents against a wider range...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New drugs for Rheumatoid arthritis

Seo YI

  • KMID: 2257380
  • Korean J Med.
  • 2009 Jan;76(1):12-17.
Since the late 1990s, based on scientific advancement and biotechnological improvement, many effective drugs such as leflunomide and biologic agents for rheumatoid arthritis (RA) have been developed. These include TNF-alpha...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Renal Transplantation in Highly Sensitized Recipients

Yoon HE, Yang CW

  • KMID: 2201911
  • J Korean Soc Transplant.
  • 2008 Jun;22(1):8-12.
Sensitized patients have a reduced chance of receiving a crossmath-negative organ, because of the presence of antibodies against a variety of human leukocyte antigen (HLA). There have been much attention...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Rituximab Treatment for Interstitial Lung Disease in a Patient with Antisynthetase Syndrome

Jo YM, Jung JK, Kim YJ, Lee SY, Lee SW, Chung WT

The clinical manifestations of antisynthetase syndrome are severe interstitial pneumonitis, mild polyarthritis, and myositis. This disease is accompanied by anti-Jo-1 antibodies and anti-Ro/SSA antibodies and occasionally by the concurrence of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Primary Glomerulonephritis

Ihm CG

  • KMID: 2267901
  • Korean J Med.
  • 2013 Jan;84(1):13-18.
Much progress has been made in the elucidation of potential pathogenetic mechanisms of glomerulonephritis such as anti-PLA2R autoantibody in membranous nephropathy and under-galactosylated IgA1 in IgA nephropathy as well as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lymphomatoid Granulomatosis with Spinal Involvement after Childhood Acute Lymphoblastic Leukemia

Kim I

Lymphomatoid granulomatosis (LYG) is a lymphoproliferative disease involving the lungs most frequently; however, it may also involve the kidneys, skin and especially the central nervous system. Unique initial presentation of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ABO Incompatability in Liver Transplantation

Song GW

Despite the great potential of ABO-incompatible (ABOi) liver transplantation (LT) for expanding the donor pool, serious concern about poor outcomes in the recipients has been a major obstacle to its...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Rituximab Use in Rheumatoid Arthritis Following Anti-TNF-Associated Tuberculosis

Kim KH, Moon KW, Heo JW, Lee WH, Lee SH, Jeong CM, Park HS

Rituximab has been shown to be effective in rheumatoid arthritis (RA) and is recommended for patients exhibiting an inadequate response to tumor necrosis factor (TNF) inhibitors. To date, there have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chronic Lymphocytic Leukemia-Era of Targeted Therapy

Shin DY, Kim I

  • KMID: 2267805
  • Korean J Med.
  • 2013 Aug;85(2):141-153.
Chronic lymphocytic leukemia (CLL) is a unique indolent B-cell leukemia which is rare in Korea. Many patients with early stage CLL do not require immediate treatment, while those with advanced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Diffuse Large B Cell Lymphoma

Kwak JY

  • KMID: 2432926
  • Korean J Intern Med.
  • 2012 Dec;27(4):369-377.
Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma in all countries and all age groups. DLBCL is potentially curable, and the outcome of patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Acute Hepatitis B by Occult HBV Infection without HbsAg Seroconversion

Jung HM, Jun DW, Min JY, Doo EY, Nam KW, Kwon YI, Kwon OW

  • KMID: 2263409
  • Korean J Med.
  • 2012 Nov;83(5):619-623.
Many studies have recently reported reactivation in hepatitis B surface antigen (HBsAg)-negative subjects with the use of biologic agents such as rituximab. However, occult hepatitis B virus infection itself has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Kikuchi-Fujimoto Disease, A Possible Complication of Rituximab Treatment

Lee J, Chang HJ, Lee ST, Kang HG, Ha IS, Cheong HI

  • KMID: 2322039
  • J Korean Soc Pediatr Nephrol.
  • 2012 Oct;16(2):138-141.
Rituximab, a chimeric anti-CD20 IgG1 monoclonal antibody, has been used as a rescue therapy for steroid-dependent or refractory nephrotic syndrome. However, the adverse effects of rituximab are yet to be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Anti-CD20 Monoclonal Antibody (Rituximab) on Recalcitrant Pemphigus Vulgaris

Kim MR, Kim SC

  • KMID: 2302072
  • Korean J Dermatol.
  • 2008 Mar;46(3):319-324.
BACKGROUND: Pemphigus is a severe blistering disorder caused by autoantibodies to desmogleins 1 and 3. Because some patients with pemphigus never enter into remission, new immunosuppressants are warranted. Rituximab is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Hobnail Hemangioma That Occurred Together with Angiolipoma

Kang YS, Kim SW, Park SH, Lee UH, Park HS, Jang SJ

  • KMID: 2247823
  • Korean J Dermatol.
  • 2009 Jun;47(6):718-721.
Hobnail hemangioma is a benign vascular tumor that typically presents as a small, solitary lesion on the trunk or limbs of young or middle-aged persons. Characteristically,the tumor has a targetoid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Posttransplantation Recurrent Glomerulonephritis: IgA Nephropathy, Membranous Nephropathy, Membranoproliferative Glomerulonephritis

Chung HC, Park J, Lee JS

  • KMID: 2324200
  • J Korean Soc Transplant.
  • 2011 Jun;25(2):81-86.
As the clinical outcomes improve in kidney transplantation, largely because of the prevention of loss due to acute rejection, the incidence of allograft loss due to recurrent glomerulonephritis have become...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Case of ABO-Incompatible Living Donor Kidney Transplantation without Blood Products in a Jehovah's Witness

Choi AS, Yu SM, Lee JH, Oh JS, Kim SM, Sin YH, Kim JK

ABO-incompatible kidney transplantations have been performed successfully in Korea without splenectomy using plasmapheresis, anti-CD20 monoclonal antibody infusions and other immunosuppressants. However, there is no report of a case of ABO-incompatible...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary malignant lymphoma of the endometrium with lumbar spine involvement

Kang GE, Jin SA, Boo HY, Pyo JY, Oh Y, Kim SR

Primary malignant lymphomas in the female genital tract are rare, but when it occurs, the cervix or the ovary are more common site than the uterine corpus. Most common symptoms...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Updated Pathophysiology of rheumatoid arthritis

Song YW

  • KMID: 2257378
  • Korean J Med.
  • 2009 Jan;76(1):1-6.
Rheumatoid arthritis is a chronic inflammatory disease that primarily affects joint synovium. Although its etiology has yet to be identified, the underlying mechanism of joint inflammation is understood as autoimmune...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary Diffuse Large B Cell Lymphoma of the Bladder

Kim SK, Kim MH, Lee N, Cha D, Kim H, Choi YJ, Chung JS, Cho GJ

Primary malignant lymphoma of the urinary bladder is a rare disease, and it accounts for only 0.2% of all the cases of extranodal lymphoma. The prognosis of primary bladder lymphoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr